Publication | Open Access
Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
26
Citations
85
References
2021
Year
MitophagyNeurochemical BiomarkersProtein AggregatesSynaptic SignalingSocial SciencesCell AutophagyAlzheimer's DiseaseAutophagyDegenerative PathologyProtein MisfoldingNeurologyNeuropathologyLysosomal OrganellesProtein Quality ControlMolecular NeuroscienceGain-of-function ToxicityLysosomal DefectsNeurodegenerationCell BiologyLysosome BiologyNeurodegenerative DiseasesProtein AggregationCellular NeuroscienceNeuroscienceMolecular NeurobiologyCellular BiochemistryMedicineLysosomal Storage Disease
The autophagy-lysosomal pathway is impaired in many neurodegenerative diseases characterized by protein aggregation, but the link between aggregation and lysosomal dysfunction remains poorly understood. Here, we combine cryo-electron tomography, proteomics, and cell biology studies to investigate the effects of protein aggregates in primary neurons. We use artificial amyloid-like β-sheet proteins (β proteins) to focus on the gain-of-function aspect of aggregation. These proteins form fibrillar aggregates and cause neurotoxicity. We show that late stages of autophagy are impaired by the aggregates, resulting in lysosomal alterations reminiscent of lysosomal storage disorders. Mechanistically, β proteins interact with and sequester AP-3 μ1, a subunit of the AP-3 adaptor complex involved in protein trafficking to lysosomal organelles. This leads to destabilization of the AP-3 complex, missorting of AP-3 cargo, and lysosomal defects. Restoring AP-3μ1 expression ameliorates neurotoxicity caused by β proteins. Altogether, our results highlight the link between protein aggregation, lysosomal impairments, and neurotoxicity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1